Affordable Access

Publisher Website

Immunoproteomic analysis of Clostridium botulinum type B secretome for identification of immunogenic proteins against botulism

  • Sharma, Arti1, 2, 3
  • Ponmariappan, S.2
  • Rani, Sarita2
  • Alam, S. I.2
  • Shukla, S.3
  • 1 Government Degree College, Prithvipur District, Niwari, 472336 India
  • 2 Defence Research & Development Establishment,
  • 3 Jiwaji University,
Published Article
Biotechnology Letters
Publication Date
Feb 25, 2021
DOI: 10.1007/s10529-021-03091-4
PMID: 33629143
PMCID: PMC7904509
PubMed Central


Objectives To identify immunogenic proteins of C. botulinum type B secretome by immunoproteomic analysis. Results In the present study, an attempt was made to elucidate the vaccine candidates/diagnostic molecules against botulism using immuno proteomic approach. C. botulinum type B secretome was elucidated when it was grown in TPGY as well as CMM media. Predominant 51 proteins were identified in both the media using 2-DE and mass spectrometry analysis. 2D gels (CMM & TPGY) were probed with respected proteins mice antiserum and obtained 17 and 10 immunogenic proteins in TPGY as well as CMM media respectively. Hypothetical protein CLOSPO_00563, ornithine carbamoyl transferase, FlaA, molecular chaperone GroEL and secreted protease proteins were found as the common immuno dominant proteins in both media. Polyclonal Antibodies raised against C. botulinum types A and E showed cross-reactivity with secretome C. botulinum type B at the lowest dilution (1:1000) but did not show cross reactivity with highest dilution (1:30,000) with C. botulinum type B secretome. Polyclonal antibodies against C. botulinum type F secretome did not show cross reactivity with C. botulinum type B secretome. Conclusions Identified immunogenic proteins can be used as vaccine candidates and diagnostic markers for the infant and wound botulism but common immunogenic proteins may be the best vaccine candidate molecule for development of vaccine as well as diagnostic system against the infant and wound botulism. Supplementary Information The online version contains supplementary material available at 10.1007/s10529-021-03091-4.

Report this publication


Seen <100 times